Lacosamide

Common brands: Vimpat, Lacosamide Oral Solution, Motpoly Xr, Keppra Xr, Keppra

Top reporter: Ucb, Inc.

Anti-epileptic Agent [EPC]Benzodiazepine [EPC]Mood Stabilizer [EPC]Corticosteroid [EPC]Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]
36,183
Total Reports
17,573
Serious Reports
3,085
Death Reports
30
Reported Reactions
Death Report Ratio: High (8.53%)

Patient Demographics

Male
13,534
Female
16,398

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Lacosamide.

# Reaction Reports % of Total
1 SEIZURE 6,706
16.7%
2 DRUG INEFFECTIVE 4,026
10.0%
3 OFF LABEL USE 3,854
9.6%
4 DIZZINESS 1,638
4.1%
5 SOMNOLENCE 1,452
3.6%
6 FATIGUE 1,423
3.5%
7 FALL 1,375
3.4%
8 EPILEPSY 1,368
3.4%
9 STATUS EPILEPTICUS 1,239
3.1%
10 OVERDOSE 1,235
3.1%
11 GENERALISED TONIC-CLONIC SEIZURE 1,150
2.9%
12 DEATH 1,058
2.6%
13 HEADACHE 1,050
2.6%
14 DRUG INTERACTION 970
2.4%
15 CONVULSION 937
2.3%
16 NAUSEA 934
2.3%
17 VOMITING 903
2.2%
18 MULTIPLE-DRUG RESISTANCE 800
2.0%
19 PRODUCT USE ISSUE 719
1.8%
20 TREMOR 718
1.8%
21 MATERNAL EXPOSURE DURING PREGNANCY 712
1.8%
22 PRODUCT DOSE OMISSION ISSUE 712
1.8%
23 CONDITION AGGRAVATED 709
1.8%
24 MEMORY IMPAIRMENT 705
1.8%
25 DEPRESSION 700
1.7%
26 RASH 673
1.7%
27 DIARRHOEA 634
1.6%
28 PARTIAL SEIZURES 630
1.6%
29 GAIT DISTURBANCE 622
1.5%
30 ANXIETY 619
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.